• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益康宁-H3:一项作为抗抑郁药的临床试验。

Gerovital-H3: a clinical trial as an antidepressant.

作者信息

Olsen E J, Bank L, Jarvik L F

出版信息

J Gerontol. 1978 Jul;33(4):514-20. doi: 10.1093/geronj/33.4.514.

DOI:10.1093/geronj/33.4.514
PMID:376578
Abstract

Twenty-five volunteers, all in their fifth decade or beyond, all with mild to moderate, nonpsychotic depression of at least several months' duration participated in a double-blind study of Gerovital vs placebo. There was no significant difference between the Gerovital and placebo groups; both groups showed significant improvement on self-rating as well as observer rating scales.

摘要

25名志愿者,年龄均在50岁及以上,均患有持续至少数月的轻度至中度非精神病性抑郁症,参与了一项关于Gerovital与安慰剂的双盲研究。Gerovital组与安慰剂组之间没有显著差异;两组在自评量表和观察者评定量表上均显示出显著改善。

相似文献

1
Gerovital-H3: a clinical trial as an antidepressant.益康宁-H3:一项作为抗抑郁药的临床试验。
J Gerontol. 1978 Jul;33(4):514-20. doi: 10.1093/geronj/33.4.514.
2
Effects of a procaine preparation (Gerovital H3) in hospitalized geriatric patients: a double-blind study.一种普鲁卡因制剂(益康宁H3)对住院老年患者的影响:一项双盲研究。
J Am Geriatr Soc. 1975 Aug;23(8):355-9. doi: 10.1111/j.1532-5415.1975.tb00326.x.
3
A trial of Gerovital H-3 in depression during senility.
Curr Ther Res Clin Exp. 1974 Jan;16(1):59-63.
4
Treatment of depression in the aged with gerovital H3: clinical efficacy and neurophysiological effects.
Psychopharmacol Bull. 1976 Apr;12(2):50-1.
5
Procaine (Gerovital): no effect on the rehabilitation result in patients with back or hip disease.普鲁卡因(杰诺维塔):对背部或髋部疾病患者的康复结果无影响。
Ann Med. 1990 Jun;22(3):151-6. doi: 10.3109/07853899009147260.
6
[Successes in novocain therapy in the control of premature ageing (author's transl)].奴佛卡因疗法在控制早衰方面的成功(作者译)
Z Alternsforsch. 1977;32(3):267-9.
7
Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales.
Pharmacopsychiatry. 1991 May;24(3):71-5. doi: 10.1055/s-2007-1014442.
8
Gerovital H3 in the treatment of the depressed aging patient.
Psychosomatics. 1974;15(1):15-9. doi: 10.1016/S0033-3182(74)71288-9.
9
Novel Augmentation Strategies in Major Depression.重度抑郁症的新型强化治疗策略
Dan Med J. 2017 Apr;64(4).
10
Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.二十碳五烯酸与二十二碳六烯酸治疗轻中度抑郁症的随机、双盲、安慰剂对照试验。
Eur Neuropsychopharmacol. 2013 Jul;23(7):636-44. doi: 10.1016/j.euroneuro.2012.08.003. Epub 2012 Aug 19.

引用本文的文献

1
Comprehensive exploration of the anticancer activities of procaine and its binding with calf thymus DNA: a multi spectroscopic and molecular modelling study.普鲁卡因的抗癌活性及其与小牛胸腺DNA结合的全面探索:多光谱和分子建模研究
RSC Adv. 2018 Mar 1;8(17):9083-9093. doi: 10.1039/c7ra13647a. eCollection 2018 Feb 28.